Craig joined IPIRA in 2016 as a Senior Licensing Officer specializing in the the life sciences. He started his career as a Research Microbiologist at the National Institutes of Health (NIH). In the early eighties, he introduced many new DNA recombinant and computer technologies to NIH. After earning MBA and MPH degrees in technology management from the University of California, Berkeley, he became involved in establishing the early federal technology transfer offices at the NIH including the National Institute of Allergy and Infectious Disease and the National Cancer Institute. He licensed out many early biotech discoveries technologies to the nascent biotech industry and, of course, major pharmaceutical companies.
In 1990’s, he embarked upon an intellectual property, business development, corporate development and clinical trials career with Novartis, Life Technologies, Myriad Genetics and Cell Genesys. He ended his private industry career with a major role in getting several drugs approved for orphan diseases at BioMarin Pharmaceuticals. Because of his interest in early stage technologies, he returned to academia including Harvard Medical School, Massachusetts Institute of Technology and the University of California, Los Angeles. He specializes in academic start-up companies and is also registered patent agent. Most recently, he helped create Orchard Therapeutics, Inc., a University of California start-up company developing gene therapies for rare immunodeficiency, metabolic and hemopoietic diseases.